Phase III Clinical Trials in Swelling Associated with Brain Tumors Celtic Pharma Development Services (CPDS) is conducting Phase III clinical trials of an investigational drug , XERECEPT, in the treatment of brain swelling (edema) associated with your tumor: XERECEPT CLINICAL TRIALS 0303 and 0501. (0303 study is now closed to enrolment) This Web site will help you learn more about XERECEPT and the Phase III clinical trials. Clinical Trial Locator Enter your zipcode or postalcode below to find a XERECEPT clinical trial near you.   What is XERECEPT? | Which Trial? | What's Involved? | Important Information Clinical Trial Locations | FAQs | Events | Glossary | Links | Contact | About Celtic Pharma | Home ©2006 Celtic Pharma Development Services, Inc. All Rights Reserved.    www.celticpharma.com